| 产品详情 |
| Edit |   |
|---|
| Product Name | AKR7A2, Recombinant, Human, aa1-359, His-tag |
|---|
| Description | Purity ~90% (SDS-PAGE). Aldo-keto reductases, such as AKR7A2, are involved in the detoxification of aldehydes and ketones. This protein can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the nonbinding AFB1 dialcohol. It may be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen. Also, it has been proposed previously to catalyze the NADPH-dependent reduction of succinic semialdehyde (SSA) to gamma-Hydroxybutyrate in human brain. Source: Recombinant protein corresponding to aa1-359 from human AKR7A2, fused to His-tag at N-terminal expressed in E. coli. Molecular Weight: ~44kD (398aa) Specific Activity: >300pmol/min/ug Unit Defintion: Defined as the amount of enzyme that catalyze the reduction 1pmole of 1,2-Naphthoquinone presence of NADPH/minute with pH 7.0 at 25°C. AA |
|---|
| Size | 100ug, 500ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | AKR7A2, Recombinant, Human, aa1-359, His-Tag (Aldo-keto reductase family 7, member A 2, Aflatoxin B1 aldehyde reductase member 2, AFAR, AFAR1, AFB1-AR1, AKR7) |
|---|
| Gene, Accession, CAS # | Accession: NP_003680 |
|---|
| Catalog # | 351068 |
|---|
| Price | |
|---|
| Order / More Info | AKR7A2, Recombinant, Human, aa1-359, His-tag from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|